These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 10226617

  • 1. Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions.
    Ventura M, Tarrago-Litvak L, Dollé V, Nguyen CH, Legraverend M, Fleury HJ, Litvak S.
    Arch Virol; 1999; 144(3):513-23. PubMed ID: 10226617
    [Abstract] [Full Text] [Related]

  • 2. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P, Prasad VR.
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [Abstract] [Full Text] [Related]

  • 3. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo.
    Zhang H, Dornadula G, Wu Y, Havlir D, Richman DD, Pomerantz RJ.
    J Virol; 1996 Jan; 70(1):628-34. PubMed ID: 8523584
    [Abstract] [Full Text] [Related]

  • 4. Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV.
    Witvrouw M, Pannecouque C, Van Laethem K, Desmyter J, De Clercq E, Vandamme AM.
    AIDS; 1999 Aug 20; 13(12):1477-83. PubMed ID: 10465070
    [Abstract] [Full Text] [Related]

  • 5. Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses.
    Nitanda T, Wang X, Somekawa K, Yuasa S, Baba M.
    Antivir Chem Chemother; 2001 May 20; 12(3):161-7. PubMed ID: 12959324
    [Abstract] [Full Text] [Related]

  • 6. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
    Miller V, Larder BA.
    Antivir Ther; 2001 May 20; 6 Suppl 3():25-44. PubMed ID: 11678471
    [Abstract] [Full Text] [Related]

  • 7. Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors.
    Andreola ML, Nguyen CH, Ventura M, Tarrago-Litvak L, Legraverend M.
    Expert Opin Emerg Drugs; 2001 Oct 20; 6(2):225-38. PubMed ID: 15989523
    [Abstract] [Full Text] [Related]

  • 8. Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.
    Domaoal RA, Demeter LM.
    Int J Biochem Cell Biol; 2004 Sep 20; 36(9):1735-51. PubMed ID: 15183341
    [Abstract] [Full Text] [Related]

  • 9. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS.
    Biochim Biophys Acta; 2002 Jul 18; 1587(2-3):296-9. PubMed ID: 12084471
    [Abstract] [Full Text] [Related]

  • 10. The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudine.
    Ambrose Z, Julias JG, Boyer PL, Kewalramani VN, Hughes SH.
    J Virol; 2006 Mar 18; 80(5):2578-81. PubMed ID: 16474164
    [Abstract] [Full Text] [Related]

  • 11. Excision of nucleoside analogs from DNA by p53 protein, a potential cellular mechanism of resistance to inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Bakhanashvili M, Novitsky E, Rubinstein E, Levy I, Rahav G.
    Antimicrob Agents Chemother; 2005 Apr 18; 49(4):1576-9. PubMed ID: 15793143
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
    Menéndez-Arias L.
    Virus Res; 2008 Jun 18; 134(1-2):124-46. PubMed ID: 18272247
    [Abstract] [Full Text] [Related]

  • 13. The effect of NNRTIs on HIV reverse transcriptase dimerization.
    Tachedjian G, Goff SP.
    Curr Opin Investig Drugs; 2003 Aug 18; 4(8):966-73. PubMed ID: 14508881
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
    Pontikis R, Dollé V, Guillaumel J, Dechaux E, Note R, Nguyen CH, Legraverend M, Bisagni E, Aubertin AM, Grierson DS, Monneret C.
    J Med Chem; 2000 May 18; 43(10):1927-39. PubMed ID: 10821705
    [Abstract] [Full Text] [Related]

  • 15. HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase.
    De Clercq E.
    Med Res Rev; 1993 May 18; 13(3):229-58. PubMed ID: 7683360
    [Abstract] [Full Text] [Related]

  • 16. The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
    Ross L, Johnson M, Graham N, Shaefer M, St Clair M.
    J Hum Virol; 1999 May 18; 2(5):290-5. PubMed ID: 10551735
    [Abstract] [Full Text] [Related]

  • 17. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.
    Zhang H, Dornadula G, Orenstein J, Pomerantz RJ.
    J Hum Virol; 2000 May 18; 3(3):165-72. PubMed ID: 10881997
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
    Agarwal HK, Chhikara BS, Doncel GF, Parang K.
    Bioorg Med Chem Lett; 2017 May 01; 27(9):1934-1937. PubMed ID: 28351588
    [Abstract] [Full Text] [Related]

  • 19. The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family.
    Chen W, Zhan P, Wu J, Li Z, Liu X.
    Curr Pharm Des; 2012 May 01; 18(27):4165-86. PubMed ID: 22621244
    [Abstract] [Full Text] [Related]

  • 20. [Establishment of pharmacological evaluation system for non-nucleoside reverse-transcriptase inhibitors resistant HIV-1].
    Cao YL, Li SX, Chen H, Guo Y.
    Yao Xue Xue Bao; 2009 Apr 01; 44(4):355-61. PubMed ID: 19545051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.